Clinical Trial Update: A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for ZYNRELEF (HTX-011) in postoperative pain after total shoulder arthroplasty with multimodal analgesia is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain Management
• Total Shoulder Arthroplasty

Drugs mentioned

• ZYNRELEF (BUPIVACAINE AND MELOXICAM)

Snippet

Sponsor: Heron Therapeutics | Conditions: Postoperative Pain, Total Shoulder Arthroplasty | Phase 4 | Status: COMPLETED